HLX70

DRUG2 trials

Sponsors

Hengenix Biotech Inc, Shanghai Henlius Biotech

Conditions

COVID 19COVID-19

Phase 1

Evaluate Safety and Pharmacokinetics of HLX70 in Healthy Adult Volunteers

WithdrawnNCT04561076

Hengenix Biotech IncCOVID 19

Start: 2020-12-09End: 2021-09-18Updated: 2022-04-01

Evaluate Safety and Pharmacokinetics of HLX70 in Healthy Adult Volunteers

WithdrawnNCT05429385

Shanghai Henlius BiotechCOVID-19

Start: 2020-12-09End: 2021-09-18Updated: 2022-06-23